Jivana Biotechnology Financing
Jivana Biotechnology Inc, Corporation just had published form D for $1.00 million equity financing. The date of first sale was . Jivana Biotechnology Inc is expected to finance itself with $1.00 million in this fundraising. The total private offering amount was $1.00 million. This form was filed on 2016-07-13. The reason for the financing was: unspecified. The fundraising still has about $1.00 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Jivana Biotechnology is based in Illinois. The company’s business is Biotechnology. The SEC form was submitted by Sidney Hopps President. The company was incorporated in 2013. The filler’s address is: 542 Franklin Ave, River Forest, Il, Illinois, 60305. Sidney Hopps is the related person in the form and it has address: 542 Franklin Ave, River Forest, Il, Illinois, 60305. Link to Jivana Biotechnology Filing: 000165962416000002.
Analysis of Jivana Biotechnology Offering
On average, companies in the Biotechnology sector, sell 73.77% of the total offering size. Jivana Biotechnology sold 0.00% of the offering. The financing is still open. The average investment size for companies in the Biotechnology industry is $3.08 million. The offering was 100.00% smaller than the average of $3.08 million. Of course this should not be taken as negative. Startups raise funds for different needs and reasons. The minimum investment for this fundraising was set at $25000. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Jivana Biotechnology Also
The Form D signed by Sidney Hopps might help Jivana Biotechnology Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.